Research programme: intranasal chlamydia vaccine - NanoBioAlternative Names: NE based chlamydia vaccine- NanoBio
Latest Information Update: 07 Dec 2015
At a glance
- Originator NanoBio Corporation
- Developer NanoBio Corporation; Queensland University of Technology
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Chlamydial infections